Setting Psoriasis Goals with Body Surface Area

This discussion focuses on translating clinical goals into patient-centered targets. Experts move beyond clinician terms like PASI scores to emphasize Body Surface Area (BSA) as a more tangible measure. The National Psoriasis Foundation guidelines set clear benchmarks: the ideal treatment goal is less than 1% BSA involvement within three months of starting therapy. "Adequate" control is defined as less than 3% BSA or at least 75% improvement from baseline.

The panel agrees these clear, published targets help align doctor and patient expectations, making conversations about progress easier. They note that modern patient expectations now actively push for higher standards, demanding near-total skin clearance. This collaborative shift, using simple BSA metrics, is crucial for defining and achieving true treatment success in psoriasis management.